Gregory W. Gironda - 01 Nov 2022 Form 3 Insider Report for Odyssey Health, Inc. (ODYY)

Role: Chief Operating Officer
Signature: /s/ Christine M. Farrell, Attorney-in-Fact for Gregory W. Gironda
Issuer symbol: ODYY
Transactions as of: 01 Nov 2022
Net transactions value: $0
Form type: 3
Filing time: 23 Nov 2022, 15:03:13 UTC
Next filing: 02 Jan 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ODYY	Stock Option - Right to Buy							01 Nov 2022	Common Stock	75,000	$0.2000	Direct
holding	ODYY	Stock Option - Right to Buy							01 Nov 2022	Common Stock	75,000	$0.2000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	75,000 shares vest, upon the execution of an agreement between Company and a strategic partner related to Company's drug ONP-002, or upon the funding for a Phase II trial that comes from a source identified by Consultant for a minimum of five million dollars ($5,000,000) closed prior to the Term.